# Clustering Approach 3 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.239476150979056	Range of duration = 0.03 to 173.79, nDeath = 57, nCensor = 74
2	AGE	ANOVA	0.354313659437963	Range of values = 40 to 85, Mean = 68.4706, StdDev = 9.21025, nMissing = 8
3	GENDER	Fisher's exact test	0.842778911290617	nTypes = 2 (FEMALE/MALE), nPatients = 104/40
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.532850603768374	Range of values = 0 to 100, Mean = 26.7857, StdDev = 39.5393, nMissing = 116
5	HISTOLOGICAL.TYPE	Chi-square test	0.285736211572351	nTypes = 4 (LUNG BASALOID SQUAMOUS CELL CARCINOMA/LUNG PAPILLARY SQUAMOUS CELL CARCINOMA/LUNG SMALL CELL SQUAMOUS CELL CARCINOMA/LUNG SQUAMOUS CELL CARCINOMA- NOT OTHERWISE SPECIFIED (NOS)), nPatients = 4/1/1/138
6	PATHOLOGY.T	Chi-square test	0.37467848373716	nTypes = 4 (T1/T2/T3/T4), nPatients = 40/83/15/6
7	PATHOLOGY.N	Chi-square test	0.30985086667435	nTypes = 3 (N0/N1/N2), nPatients = 92/40/12
8	PATHOLOGICSPREAD(M)	Chi-square test	0.529772479503008	nTypes = 3 (M0/M1/MX), nPatients = 119/1/22, nMissing = 2
9	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.244826681540201	nTypes = 2 (NO/YES), nPatients = 136/8
10	NEOADJUVANT.THERAPY	Fisher's exact test	0.668235619590627	nTypes = 2 (NO/YES), nPatients = 128/16